HCP
76
2
LB
82
19
ALLE
55
2
CTAS
64
2
PLD
50
7
CINF
48
3
FMC
41
-3
ILMN
46
-4
INTU
60
2
WM
82
3
EXR
60
5
AIG
42
-2
LLY
50
11
GT
67
3
RF
66
3
EIX
69
7
CA
22
12
WHR
70
2
COST
66
6
HBI
59
-6
HCP
76
2
LB
82
19
ALLE
55
2
CTAS
64
2
PLD
50
7
CINF
48
3
FMC
41
-3
ILMN
46
-4
INTU
60
2
WM
82
3
EXR
60
5
AIG
42
-2
LLY
50
11
GT
67
3
RF
66
3
EIX
69
7
CA
22
12
WHR
70
2
COST
66
6
HBI
59
-6
Financhill
Back

Dermata Therapeutics Vs. Pieris Pharmaceuticals Industry Stock Comparison

Sell
26

DRMA
Dermata Therapeutics

Last Price:
1.35
Seasonality Move:
-53.36%
Sell
48

PIRS
Pieris Pharmaceuticals

Last Price:
16.31
Seasonality Move:
11.68%
Sell
26
Dermata Therapeutics (DRMA) is a Sell

Is Dermata Therapeutics a Buy, Sell or Hold?

  • The current Dermata Therapeutics [DRMA] share price is $1.39. The Score for DRMA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • DRMA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Pieris Pharmaceuticals (PIRS) is a Sell

Is Pieris Pharmaceuticals a Buy, Sell or Hold?

  • The current Pieris Pharmaceuticals [PIRS] share price is $16.83. The Score for PIRS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • PIRS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DRMA Stock Price Chart

What is Dermata Therapeutics's stock price today?

  • The Dermata Therapeutics share price today is $1.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRMA is experiencing slight selling pressure.

PIRS Stock Price Chart

What is Pieris Pharmaceuticals's stock price today?

  • The Pieris Pharmaceuticals share price today is $16.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PIRS is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRMA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 47.97 Sell
Chaikin Money Flow: -88554 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.28 - 1.48) Buy
Bollinger Bands (100): (1.41 - 2.33) Sell

PIRS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 51.01 Buy
Chaikin Money Flow: 6141 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.36 - 17.04) Buy
Bollinger Bands (100): (11.09 - 18.55) Buy

DRMA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.3 Buy
20-day SMA: 1.38 Buy
50-day SMA: 1.52 Sell
200-day SMA: 3.68 Sell
8-day EMA: 1.34 Buy
20-day EMA: 1.38 Buy
50-day EMA: 1.58 Sell
200-day EMA: 6.76 Sell

PIRS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.89 Sell
20-day SMA: 16.81 Buy
50-day SMA: 16.79 Buy
200-day SMA: 13.73 Buy
8-day EMA: 16.83 Buy
20-day EMA: 16.8 Buy
50-day EMA: 16.44 Buy
200-day EMA: 17.57 Sell

Dermata Therapeutics Earnings Growth & DRMA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Pieris Pharmaceuticals Earnings Growth & PIRS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.09 per share.

Dermata Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Pieris Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):